Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience.

Oliva S, Martello M, Saraci E, Armuzzi S, Solli V, Barbato S, Belotti A, Bolli N, Bono C, Buccisano F, Chiarini M, Irno Consalvo MA, Cordone I, Drandi D, Galimberti S, Genuardi E, Giustini V, Guerrini F, Lionetti M, Maheda A, Marino S, Masi S, Matera A, Mengarelli A, Parrinello NL, Roccaro AM, Romano A, Rossi G, Taurisano B, Tonini A, Trimarco V, Triolo AM, Vigliotta I, Zambello R, Bruno B, Cavo M, Zamagni E, Terragna C

Open source

DOI
10.1002/cam4.71678
Published
2026 Mar
Container
Cancer medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cam4.71678,
  title = {Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience.},
  author = {Oliva S and Martello M and Saraci E and Armuzzi S and Solli V and Barbato S and Belotti A and Bolli N and Bono C and Buccisano F and Chiarini M and Irno Consalvo MA and Cordone I and Drandi D and Galimberti S and Genuardi E and Giustini V and Guerrini F and Lionetti M and Maheda A and Marino S and Masi S and Matera A and Mengarelli A and Parrinello NL and Roccaro AM and Romano A and Rossi G and Taurisano B and Tonini A and Trimarco V and Triolo AM and Vigliotta I and Zambello R and Bruno B and Cavo M and Zamagni E and Terragna C},
  year = {2026},
  journal = {Cancer medicine},
  doi = {10.1002/cam4.71678},
  url = {https://doi.org/10.1002/cam4.71678}
}

RIS

TY  - JOUR
TI  - Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience.
AU  - Oliva S
AU  - Martello M
AU  - Saraci E
AU  - Armuzzi S
AU  - Solli V
AU  - Barbato S
AU  - Belotti A
AU  - Bolli N
AU  - Bono C
AU  - Buccisano F
AU  - Chiarini M
AU  - Irno Consalvo MA
AU  - Cordone I
AU  - Drandi D
AU  - Galimberti S
AU  - Genuardi E
AU  - Giustini V
AU  - Guerrini F
AU  - Lionetti M
AU  - Maheda A
AU  - Marino S
AU  - Masi S
AU  - Matera A
AU  - Mengarelli A
AU  - Parrinello NL
AU  - Roccaro AM
AU  - Romano A
AU  - Rossi G
AU  - Taurisano B
AU  - Tonini A
AU  - Trimarco V
AU  - Triolo AM
AU  - Vigliotta I
AU  - Zambello R
AU  - Bruno B
AU  - Cavo M
AU  - Zamagni E
AU  - Terragna C
PY  - 2026
JO  - Cancer medicine
DO  - 10.1002/cam4.71678
UR  - https://doi.org/10.1002/cam4.71678
ER  - 

APA

S, O., M, M., E, S., S, A., V, S., S, B., A, B., N, B., C, B., F, B., M, C., MA, I. C., I, C., D, D., S, G., E, G., V, G., F, G., M, L., A, M., S, M., S, M., A, M., A, M., NL, P., AM, R., A, R., G, R., B, T., A, T., V, T., AM, T., I, V., R, Z., B, B., M, C., E, Z., & C, T. (2026). Next Generation Flow and Next Generation Sequencing for Measurable Residual Disease Assessment in Multiple Myeloma Patients: A Real-Life Italian Multicenter Harmonization Experience.. Cancer medicine. https://doi.org/10.1002/cam4.71678

Source records